In 2024, the Parenteral Nutrition Market in Latin America (LATAM), particularly in key economies such as Brazil, Mexico, Argentina, Colombia, Chile, and Peru, grew significantly due to various drivers and prevailing trends.
Drivers contributing to market expansion included increasing healthcare investments, a surge in chronic disease cases, and advancements in parenteral nutrition. Governments across the region allocated more resources towards healthcare to meet increasing demand, specifically in Brazil and Mexico. An upsurge in chronic diseases like cancer and diabetes boosted the consumption of parenteral nutrition in Argentina and Chile, where such conditions are prevalent. Lastly, Colombia saw advancements in parenteral nutrition technology related to customization and administration, enhancing its adoption across the region.
Simultaneously, certain trends shaped this market. The increasing preference for home healthcare over hospitalization, driven by cost-effectiveness, independence, and convenience, steered more patients towards parenteral nutrition systems that can be used at home. Moreover, the rise of e-pharmacies in Peru facilitated the greater accessibility of these products. Lastly, large pharmaceutical firms across LATAM started partnering with local companies to foster growth and meet the regional demand, exemplified by strategic collaborations in Brazil and Argentina.
The primary sectors contributing to this growth were healthcare and retail, including online platforms, with chronic disease patients representing a considerable proportion of end users.